Hypertension in Women: The Role of Menopause

Description

Learner Objectives
Upon completion of this activity, you should be able to:

Describe the prevalence of hypertension throughout a woman’s lifecycle.
Explain the pathophysiology and overlapping relationship between menopausal symptoms and hypertension as comorbidities and risk factors in women.
Distinguish hypertension from menopause symptomatology in women for timely identification and management within the CV healthcare team.

Faculty

Erin D. Michos, MD, MHS, FACC
Johns Hopkins University School of Medicine
Baltimore, Maryland
Disclosures

Consultant Fees/Honoraria: Amgen Inc, Arrowhead, AstraZeneca Pharmaceuticals, Bayer Healthcare Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Inc, Edwards Lifesciences, Eli Lilly and Company, Esperion, Ionis, Medtronic, Merck & Co., Inc., New Amsterdam, Novartis Corporation, Novo Nordisk Inc., Zoll

Planning Committee
Purvi Parwani, MBBS MPH FACC
Loma Linda University Health
Loma Linda, California
Disclosures
Speaker’s Bureau: BMS
Consultant Fees/Honoraria: Zoll

Chris Owen, ACNP-BC, AACC
American College of Cardiology
Washington, DC
Disclosures
Consultant Fees/Honoraria: SilkRoad

Summary

Availability:

On-Demand

Access expires on Apr 25, 2026

Cost:

FREE

Credit Offered:

0.25 CME Credit

0.25 CNE Credit

0.25 AAPA Credit

0.25 ABIM-MOC Point

0.25 IPCE Credit